MT1 and MT2 melatonin receptors play opposite roles in brain cancer progression
- 3 January 2021
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 99 (2) , 289-301
Abstract
Primary brain tumors remain among the deadliest of all cancers. Glioma grade IV (glioblastoma), the most common and malignant type of brain cancer, is assoKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (14/27287-0, 17/24287-8, 14/23830-1, 13/13691-1, 15/23348-8, 14/50943-1)
This publication has 65 references indexed in Scilit:
- Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinomaJournal of Pineal Research, 2013
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff OptimizationPLOS ONE, 2012
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In VivoCell Metabolism, 2012
- Maintenance of primary tumor phenotype and genotype in glioblastoma stem cellsNeuro-Oncology, 2011
- Metabolic state of glioma stem cells and nontumorigenic cellsProceedings of the National Academy of Sciences, 2011
- Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and InterpretationPLOS ONE, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005